US Drug Supply Faces Critical China Dependency, New Analysis Reveals
A comprehensive analysis reveals America’s deep dependence on China for pharmaceutical raw materials, with nearly 700 medications using chemicals exclusively sourced from Chinese suppliers. Experts warn this reliance could jeopardize patient access to essential medicines during trade disputes or global health crises.
Widespread Pharmaceutical Dependence on Chinese Chemicals
America’s drug supply chain faces significant vulnerability due to heavy reliance on Chinese-produced raw materials, according to a new analysis from U.S. Pharmacopeia. The report indicates that nearly 700 medications approved for use in the United States depend on chemical substances exclusively manufactured in China, raising concerns about supply stability amid escalating geopolitical tensions.